The Emerging Link Between Endocrine Disorders, Diet, and Canine Megaoesophagus

Article

Canine Neurology Veterinary Nutrition Acquired Megaoesophagus Canine Hypothyroidism Myasthenia Gravis in Dogs Dry Dog Food Endocrine Disorders in Dogs

The Emerging Link Between Endocrine Disorders, Diet, and Canine Megaoesophagus

The Emerging Link Between Endocrine Disorders, Diet, and Canine Megaoesophagus

Megaoesophagus is traditionally recognised as a disorder involving reduced oesophageal motility and diffuse oesophageal dilatation. However, increasing evidence suggests that the disease may reflect broader neuromuscular and systemic dysfunction rather than an isolated oesophageal problem.

The condition develops secondary to impaired peristalsis caused by neuromuscular abnormalities. Acquired megaoesophagus may occur in association with diseases such as myasthenia gravis, hypothyroidism, hypoadrenocorticism, polymyopathies, and dysautonomia^1,2.

Why Hypothyroidism Deserves More Attention

Among the associated disorders, hypothyroidism has gained increasing attention because of its potential neurological impact on oesophageal function.

In the evaluated dogs, serum T4 values were lower in affected animals compared to controls. Notably, 77.8% of affected dogs had serum T4 levels below 2 µg/dL. Although the decrease was not statistically significant, the findings remain clinically important¹.

Megaoesophagus is considered one of the peripheral nervous system syndromes associated with canine hypothyroidism. The proposed mechanisms include:

Impaired axonal transport due to decreased neuronal metabolism

Demyelination caused by mucopolysaccharide deposition within Schwann cells and connective tissue³

For clinicians, this highlights the importance of including thyroid evaluation in dogs presenting with chronic regurgitation, particularly when dermatological or neuromuscular signs coexist.

Clinical Clues Beyond Regurgitation

While regurgitation and weight loss were present in all affected dogs, several additional findings may help clinicians suspect underlying systemic disease.

Observed clinical signs included¹:

Skin lesions including alopecia, scaling, crusting, and poor hair coat quality

Muscle wasting

Eye lesions such as corneal opacity and cataracts

Respiratory distress and cough secondary to aspiration pneumonia

These findings reinforce the need for complete systemic evaluation rather than focusing solely on gastrointestinal symptoms.

The Possible Dietary Connection

One of the more interesting observations surrounding acquired idiopathic megaoesophagus is its potential association with commercial dry dog food.

A case-control study demonstrated a strong correlation between disease occurrence and consumption of dry dog food⁴. Further reports by Hurley et al. (2021) described outbreaks associated with two commercial dry food brands⁵.

Although definitive causation has not been established, these findings emphasise the importance of obtaining a detailed dietary history in affected patients.

Questions veterinarians should routinely ask include:

Type of commercial diet fed

Duration of feeding

Recent dietary changes

Feeding practices and meal consistency

Myasthenia Gravis: A Key Differential Diagnosis

Myasthenia gravis remains one of the most significant causes of secondary megaoesophagus. McBrearty et al. reported that 26% of dogs with secondary megaoesophagus tested positive for anti-acetylcholine receptor antibody titres⁶.

Clinically, veterinarians should suspect myasthenia gravis in dogs presenting with:

Generalised weakness

Exercise intolerance

Episodic collapse

Concurrent regurgitation

Early identification is particularly important because some affected dogs may improve significantly with targeted therapy.

Diagnostic and Monitoring Strategies

Radiography continues to play a central role in diagnosis. Lateral cervical and thoracic radiographs help identify oesophageal dilatation, while contrast studies can confirm impaired motility¹.

In practice, clinicians should also consider:

Thoracic imaging to assess aspiration pneumonia

Complete blood count evaluation

Serum biochemical analysis

Thyroid hormone testing

Acetylcholine receptor antibody testing where indicated

The study findings of leukocytosis, neutrophilia, and eosinophilia further support the importance of monitoring for secondary pulmonary complications.

Conclusion

Canine megaoesophagus is increasingly being recognised as a multifactorial disorder with neurological, endocrine, and possibly dietary influences. For veterinarians, successful case management depends on identifying underlying triggers, recognising systemic clinical clues, and proactively addressing complications such as aspiration pneumonia.

A comprehensive diagnostic approach, rather than focusing only on oesophageal dilatation, can help clinicians improve both long-term outcomes and quality of life in affected dogs.

Reference

Fasil PM, Geethanjali PV, Mariya AC, Johnson J, Uvais NM, Shyma VH, Dinesh PT, Deepa PM. Epidemiological and Clinco-Pathological studies on megaoesophagus in dogs. International J. Veterinary Sciences and Animal Husbandry. 2024;9:1094-7. https://www.researchgate.net/profile/Dinesh-Parathazhathayil/publication/378182638_Epidemiological_and_Clinco-Pathological_studies_on_megaoesophagus_in_dogs/links/65cc5a51790074549783d65a/Epidemiological-and-Clinco-Pathological-studies-on-megaoesophagus-in-dogs.pdf

Arnell K, Hill S, Hart J, Richter K. Persistent regurgitation in four dogs with caudal esophageal neoplasia. Journal of the American Animal Hospital Association. 2013 Jan 1;49(1):58-63. https://doi.org/%2010.5326/JAAHA-MS-5826

Ko GB, Kim J, Choi HI, Moon MY, Suh GH, Kim HJ. Improvement of megaesophagus after treatment of concurrent hypothyroidism. Journal of veterinary clinics. 2018;35(1):19-21. https://www.academia.edu/download/92996245/JVC-35-1-19.pdf